Company Filing History:
Years Active: 2023
Title: Galit Mishan Eisenberg: Innovator in Cancer Immunotherapy
Introduction
Galit Mishan Eisenberg is a prominent inventor based in Modiin, Israel. She has made significant contributions to the field of cancer immunotherapy, focusing on innovative therapeutic modalities. Her work aims to improve treatment options for cancer patients through advanced scientific research.
Latest Patents
Galit Mishan Eisenberg holds a patent titled "Modulation of SLAMF6 splice variants for cancer therapy." This invention relates to cancer immunotherapy, particularly to improved therapeutic modalities involving the specific modulation of the expression and/or activity of SLAMF6 splice variants. The patent provides compositions and methods for cancer therapy, including adoptive T cell transfer therapies, cell vaccines, and polypeptide-based medicaments. Notably, the invention emphasizes the selective augmentation of SLAMF6 variant 3 (SLAMF6) N expression or activity on T cells and/or tumor cells.
Career Highlights
Galit is associated with Hadasit Medical Research Services and Development Ltd., where she continues to advance her research in cancer therapies. Her innovative approach has the potential to transform treatment strategies and improve patient outcomes.
Collaborations
Galit has collaborated with notable colleagues, including Michal Lotem and Emma Hajaj. These partnerships enhance her research efforts and contribute to the development of effective cancer therapies.
Conclusion
Galit Mishan Eisenberg is a trailblazer in the field of cancer immunotherapy, with her patent reflecting a commitment to advancing medical science. Her work exemplifies the impact of innovation in improving cancer treatment options.